Product Description
| Cat Number | PP-500 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | EphB2 - ADDL interaction inhibitor |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | Protein-protein interactions |
| Sequence Three Letter Code | H-Val-Phe-Gln-Val-Arg-Ala-Arg-Thr-Val-Ala-OH |
| Molecular Formula | C51H87N17O13 |
| Sl Sequence | VFQVRARTVA |
| Solubility | Soluble in saline |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Shi et al (2016) Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease. J Neurosci. 36(47) 11959 PMID: 27881781Bruzzoni-Giovanelli (2018) Interfering peptides targeting protein-protein interactions: the next generation of drugs? Drug Discov Today 23(2) 272 PMID: 29097277Yang (2021) Transferrin-Pep63-liposomes accelerate the clearance of Aβ and rescue impaired synaptic plasticity in early Alzheimer's disease models. Cell Death Discov. 7(1) 256 PMID: 34548476 Related areasAll peptides >All protein-protein interaction modulators >All neuroscience research categories > |
| Note | The product is for research use only |
Share Item: